High rates of radical treatment for stage III non-small cell lung cancer (NSCLC) at Barking, Havering & Redbridge University Hospitals NHS Trust (BHRUT)

被引：0
作者：
Yasar, Binnaz [1 ]
Bloomfield, Adam [2 ]
Tarver, Kathryn [1 ]
Ball, Simon [2 ]
机构：
[1] Barking Havering & Redbirdge Univ Hosp NHS Trust, Romford, Essex, England
[2] Queens Hosp, Romford, Essex, England
来源：
LUNG CANCER | 2021年 / 156卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
120
引用
收藏
页码：S49 / S50
页数：2
相关论文
共 2 条
  • [1] Stage III Non-small Cell Lung Cancer Management in England
    Adizie, J. B.
    Khakwani, A.
    Beckett, P.
    Navani, N.
    West, D.
    Woolhouse, I
    Harden, S., V
    [J]. CLINICAL ONCOLOGY, 2019, 31 (10) : 688 - 696
  • [2] Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
    Antonia, S. J.
    Villegas, A.
    Daniel, D.
    Vicente, D.
    Murakami, S.
    Hui, R.
    Kurata, T.
    Chiappori, A.
    Lee, K. H.
    de Wit, M.
    Cho, B. C.
    Bourhaba, M.
    Quantin, X.
    Tokito, T.
    Mekhail, T.
    Planchard, D.
    Kim, Y. -C.
    Karapetis, C. S.
    Hiret, S.
    Ostoros, G.
    Kubota, K.
    Gray, J. E.
    Paz-Ares, L.
    Carpeno, J. de Castro
    Faivre-Finn, C.
    Reck, M.
    Vansteenkiste, J.
    Spigel, D. R.
    Wadsworth, C.
    Melillo, G.
    Taboada, M.
    Dennis, P. A.
    Ozguroglu, M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) : 2342 - 2350
1